Rasburicase Alternatives Compared
Rasburicase | Allopurinol | Zyloprim (allopurinol) |
|
---|
Rasburicase | Allopurinol | Zyloprim (allopurinol) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Hyperuricemia Secondary to Chemotherapy. Rasburicase may also be used for purposes not listed in this medication guide. |
Prescription only
Allopurinol is used in the treatment of high uric acid levels associated with gout, kidney stones, and cancer treatment, it should not be used for asymptomatic high uric acid levels. If a rash occurs... View more |
Prescription only
Prescribed for Gout, Calcium Oxalate Calculi with Hyperuricosuria, Hyperuricemia Secondary to Chemotherapy. Zyloprim may also be used for purposes not listed in this medication guide. |
Related suggestions Hyperuricemia Secondary to Chemotherapy
|
|||||||
More about Rasburicase | More about Allopurinol | More about Zyloprim (allopurinol) | ||||||||
Ratings & Reviews | ||||||||||
Be the first to share your experience with this drug. |
Allopurinol has an average rating of 7.5 out of 10 from a total of 88 ratings on Drugs.com. 63% of reviewers reported a positive effect, while 19% reported a negative effect. |
Zyloprim has an average rating of 9.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
Drug Class | ||||||||||
Side Effects | ||||||||||
Generic Availability | ||||||||||
N/A |
Lower cost generic |
|||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Allopurinol prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms Available | ||||||||||
N/A |
|
|
||||||||
Brand Names | ||||||||||
Elitek, Fasturtec | Aloprim, Zyloprim | Other allopurinol brands include: Aloprim | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
N/A |
27 hours |
27 hours |
||||||||
CSA Schedule ** View glossary of terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 28 drugs are known to interact with Rasburicase:
|
A total of 432 drugs are known to interact with Allopurinol:
|
A total of 432 drugs are known to interact with Zyloprim:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
N/A |
August 19, 1966 |
August 19, 1966 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.